| Ewa Kluk, | |
|
326 W Main St Ste 205, Milford, CT 06460-2560 | |
| (203) 296-3002 | |
| Not Available |
| Full Name | Ewa Kluk |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 326 W Main St Ste 205, Milford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013647163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Secondary |
| 101YP2500X | Counselor - Professional | 7177 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ewa Kluk, 2 Waterside Xing Ste 401, Windsor, CT 06095-1588 Ph: (860) 697-3351 | Ewa Kluk, 326 W Main St Ste 205, Milford, CT 06460-2560 Ph: (203) 296-3002 |
News Archive
Abbott announced today that it will expand its existing agreement with GlaxoSmithKline Biologicals S.A. to include the development of an additional companion diagnostic test in support of GSK's cancer immunotherapy research program.
According to a new study featured in the March issue of Radiology, single-slice magnetic resonance imaging (MRI) is a fast, non-invasive way to measure intra-abdominal fat, which when excessive, may put children and teenagers at risk for developing heart disease, diabetes and other illnesses.
Biomedical scientist Kimberly L. Koss, PhD, is fighting an extremely aggressive and difficult-to-treat form of breast cancer.
Cancer Research UK scientists have discovered cancer-blocking activity for genes carried on chromosome 21 - an extra copy of which is carried by people with Down's syndrome, reveals research published in Nature.
BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has approved the design of a single, pivotal, Phase III clinical trial evaluating its lead product, OncoVEX (GM-CSF), for the first-line treatment of patients with squamous cell cancer of the head and neck.
› Verified 8 days ago
Lamont Dixon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 949 Bridgeport Ave, Milford, CT 06460 Phone: 203-878-6365 | |
Berthania Boursiquot, LPCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 949 Bridgeport Ave, Milford, CT 06460 Phone: 203-878-6365 Fax: 203-301-2397 | |
Sheila M. Sneed, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 203 High St, Milford, CT 06460 Phone: 203-874-6270 | |
Joanne C Prete, ATR, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4 Oxford Rd Ste C1, Milford, CT 06460 Phone: 203-600-8900 | |
Douglas William Roberto, DARC, RCP Counselor Medicare: Not Enrolled in Medicare Practice Location: 14 Village Rd, Milford, CT 06460 Phone: 203-843-4143 | |
Margaret Burton, Counselor Medicare: Not Enrolled in Medicare Practice Location: 580 Naugatuck Ave, Milford, CT 06461 Phone: 475-331-2100 |